Dr J C Pompe

Dr J C Pompe
Discoverer of Pompe disease

About this blog

What you can read here is the story of the development of enzyme replacement therapy (ERT), the first effective treatment for Pompe disease. It is an incredible story, rich with events, characters and science. Above all, it is the story of an international community of scientists, doctors, patients and companies, working together towards a common goal.

It is not a story that features in Geeta Anand's book, The Cure , or the film based on it, Extraordinary Measures despite the fact that they are ostensibly about the development of ERT for Pompe ( you can link straight to the relevant articles covering the events described in the book and film here, here and here).

This blog represents my small attempt to set the record straight and to give the story back to its rightful owners - the international Pompe community. It is written here in roughly chronological order i.e. you'll need to start at the bottom of the April 2009 archive page and work your way up.

It is also a personal account and, although I've tried to make it as objective as possible, there is an inevitable degree of subjectivity. For that reason I have included contributions from other members of the worldwide Pompe community and would be delighted to receive more. Feedback is also welcome.

Search This Blog

Saturday, 2 January 2010

A milestone

Following the release of the Pharming/Genzyme results, we held an IPA telephone conference on 20 March 2000. This marked an important milestone.

One of the items concerned the extension of the trial mentioned in the press release - round 8 babies would be treated at Essen, in Germany. At the moment they had no-one and were actively recruiting. If I can add a personal note, this meant that, after 7 years of speaking with distressed parents from all over the globe, such parents could now be given something a bit better than sympathy. There was now a treatment, it had been shown to be of some benefit - and there were places available on a clinical trial right now. I felt a weight lifting. How much more must that have meant to doctors giving the diagnosis and the parents who received it.

We also agreed to co-operate with the Rotterdam team in drawing up a database of Pompe patients and their clinical progress and symptoms.

We were now waiting for two things - the results from the Duke/Synpac trial and the plan to commercialise the alpha-glucosidase product.  The latter turned out to be more complex than we could have imagined at the time.

No comments:

Post a Comment